Create a narrative

Cerus Community

NasdaqGM:CERS Community

1 Narratives written by author
0 Comments on narratives written by author
9 Fair Values set on narratives written by author

AN

AnalystConsensusTarget

AnalystConsensusTarget

Based on Analyst Price Targets

Aging Population And Regulatory Approvals Will Open New Markets

Key Takeaways Growing demand for blood safety and regulatory momentum are driving increased adoption of INTERCEPT products, supporting sustainable revenue and market share expansion. Shifting to a recurring revenue model with product innovation and geographic expansion boosts sales predictability and potential for higher margins.

US$4.67

FV

69.1% undervalued

13.38%

Revenue growth p.a.

0

0

9

23 days ago